Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AKYA |
---|---|---|
09:32 ET | 990 | 2.25 |
09:41 ET | 100 | 2.2297 |
09:56 ET | 100 | 2.23 |
09:57 ET | 100 | 2.23 |
10:01 ET | 200 | 2.23 |
10:03 ET | 358 | 2.21 |
10:06 ET | 700 | 2.22 |
10:08 ET | 144 | 2.2106 |
10:15 ET | 31674 | 2.2 |
10:17 ET | 10355 | 2.2 |
10:19 ET | 2071 | 2.22 |
10:21 ET | 200 | 2.21 |
10:24 ET | 100 | 2.21 |
10:28 ET | 100 | 2.2 |
10:30 ET | 5299 | 2.2 |
10:32 ET | 534 | 2.198 |
10:33 ET | 100 | 2.18 |
10:35 ET | 100 | 2.19 |
10:37 ET | 3099 | 2.16 |
10:39 ET | 22488 | 2.205 |
10:50 ET | 100 | 2.19 |
10:53 ET | 500 | 2.2 |
10:55 ET | 100 | 2.2 |
10:57 ET | 12155 | 2.21 |
11:00 ET | 2253 | 2.22 |
11:02 ET | 1271 | 2.215 |
11:04 ET | 13851 | 2.25 |
11:06 ET | 300 | 2.25 |
11:09 ET | 113 | 2.25 |
11:11 ET | 1423 | 2.22 |
11:13 ET | 100 | 2.22 |
11:15 ET | 300 | 2.2016 |
11:18 ET | 100 | 2.2 |
11:26 ET | 100 | 2.2 |
11:27 ET | 100 | 2.2 |
11:29 ET | 1909 | 2.195 |
11:31 ET | 1200 | 2.2 |
11:33 ET | 677 | 2.2296 |
11:38 ET | 100 | 2.21 |
11:40 ET | 200 | 2.21 |
11:45 ET | 200 | 2.21 |
11:56 ET | 100 | 2.21 |
12:00 ET | 100 | 2.21 |
12:02 ET | 100 | 2.21 |
12:05 ET | 300 | 2.21 |
12:12 ET | 2433 | 2.21 |
12:14 ET | 100 | 2.2 |
12:16 ET | 700 | 2.2 |
12:18 ET | 100 | 2.2 |
12:20 ET | 398 | 2.2008 |
12:23 ET | 4146 | 2.21 |
12:36 ET | 100 | 2.21 |
12:38 ET | 100 | 2.205 |
12:50 ET | 100 | 2.21 |
12:52 ET | 100 | 2.21 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Akoya Biosciences Inc | 108.2M | -1.5x | --- |
Fonar Corp | 102.0M | 10.3x | -15.67% |
Harvard Bioscience Inc | 120.3M | -14.3x | --- |
Xylo Technologies Ltd | 3.6M | -0.2x | --- |
ViewRay Inc | 18.3K | 0.0x | --- |
Vaso Corp | 42.1M | 11.6x | --- |
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $108.2M |
---|---|
Revenue (TTM) | $93.6M |
Shares Outstanding | 49.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.47 |
Book Value | $1.09 |
P/E Ratio | -1.5x |
Price/Sales (TTM) | 1.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -66.06% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.